Contribution: Industrial Research Assistance Program – Contributions to Firms
Mindstride Labs, Inc.
$50,000.00
MindStride Health Connect
FY 2024-25 · 2024-09-16
Summary
Mindstride is developing a commercial platform to make high-quality mental healthcare more accessible. With this project, the firm plans to improve their platform efficiency and productivity for caregivers and doctors.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Ottawa|Ottawa, Ontario, Canada
Recipient Type
For-profit organization
Business Number
717919948
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2024-09-16 | 2024-25 | $50,000.00 |
| 1 | 2024-09-16 | 2024-25 | $50,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 41 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 41 jours.
Agreement End Date
2025-03-15
Agreement Number
1023059
Agreement Start Date
2024-09-16
Agreement Title
MindStride Health Connect
Agreement Title (French)
MindStride Health Connect
Agreement Type
Contribution
Agreement Value
$50,000.00
Amendment Date
2025-02-06
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Mindstride is developing a commercial platform to make high-quality mental healthcare more accessible. With this project, the firm plans to improve their platform efficiency and productivity for caregivers and doctors.
Description (French)
Mindstride développe une plateforme commerciale pour rendre plus accessibles des soins de santé mentale de haute qualité. Avec ce projet, l’entreprise prévoit d’améliorer l’efficacité et la productivité de leur plateforme pour les soignants et les médecins.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Ottawa Centre
Federal Riding (French)
Ottawa-Centre
Federal Riding Number
35075
NAICS Code
621990
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
717919948
Recipient City
Ottawa|Ottawa
Recipient Country
CA
Recipient Legal Name
Mindstride Labs, Inc.
Recipient Operating Name
Mindstride
Recipient Postal Code
K2C 3T2
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2024-2025-Q3-1023059
